.Pharmacolibrary.Drugs.A_AlimentaryTractAndMetabolism.A07E_IntestinalAntiinflammatoryAgents.A07EC03_Olsalazine.Olsalazine .Pharmacolibrary.Drugs.A_AlimentaryTractAndMetabolism.A07E_IntestinalAntiinflammatoryAgents.A07EC03_Olsalazine.Olsalazine| name: | Olsalazine | |
| ATC code: | A07EC03 | route: | oral |
| compartments: | 1 | |
| dosage: | 500 | mg |
| volume of distribution: | 16.7 | L |
| clearance: | 17.7 | L/h |
| other parameters in model implementation | ||
Olsalazine is an anti-inflammatory drug used primarily in the treatment of inflammatory bowel disease, particularly ulcerative colitis. It is a prodrug that is converted in the colon to mesalazine (5-aminosalicylic acid), the active moiety. Olsalazine is approved for use in the maintenance of remission of ulcerative colitis.
Pharmacokinetic parameters in healthy adult volunteers following oral administration.